Converge International receives investment from the Victorian Business Growth Fund

Converge International has raised funds from the Victorian Business Growth Fund. The investment was managed by ROC Partners and the capital raised will be used to fund the acquisition of HeadUp Labs and support future growth.

Converge is Australia’s most established B2B workplace mental health and wellbeing service provider, enabling corporate and government organizations to provide their employees with the wellbeing support they need, reducing risk, improving employee resilience and increasing workforce participation.

Oaklins’ team in Australia advised Converge International on their investment from the Victorian Business Growth Fund.

Service

Funding, debt advisory & ECM

Parties

“From the commencement of the engagement with Oaklins, we were delighted by the speed with which they were able to grasp Converge’s vision and strategy, understand and provide advice on the ‘buy’ vs ‘build’ options and identify highly synergistic value-adding acquisition opportunities, the best sources of capital, and act on behalf of Converge to progressively finetune the approaches and support the buy-side and investor negotiations. At all times the team provided Converge with advice that was proactive, wise, and transparent. It has been a genuine partnership which we look forward to continuing with them as we seek further M&A opportunities to support our growth.”

Terry Winters

Chairman, Converge International

Talk to the deal team

Scott McInnes

Managing Director

Melbourne, Australia
Oaklins Henslow

View profile Get in touch

Related deals

Bolster Investment Partners has acquired a majority stake in Eternal Sun

Private Equity | Energy

Bolster Investment Partners has acquired a majority stake in Eternal Sun

Bolster Investment Partners, a Netherlands-based investment firm, has acquired a majority stake in Eternal Sun, a global technology leader in advanced solar panel testing equipment, from ABN AMRO Sustainable Impact Fund, a private impact fund based in the Netherlands, and Vermec, a Belgium-based investment firm.

Learn more

Cerbios-Pharma has been acquired by HAS Healthcare

Healthcare

Cerbios-Pharma has been acquired by HAS Healthcare

Cerbios-Pharma S.A. has been acquired by HAS Healthcare Advanced Synthesis S.A., forming a leading global contract development and manufacturing organization (CDMO) group. This transaction results in a seamless integration of complementary capabilities, combining extensive expertise in production, chemical and biological sciences and technical excellence, all designed to meet the evolving demands of the global pharmaceutical sector.

Learn more

Gewiss S.p.A. has completed a mandatory public tender offer for Beghelli S.p.A.

Other Industries

Gewiss S.p.A. has completed a mandatory public tender offer for Beghelli S.p.A.

Gewiss S.p.A. has successfully finalized a mandatory public tender offer for Beghelli S.p.A.

Learn more